Cohance Lifesciences promoter sells shares for debt repayment

Jusmiral Holdings Limited, a promoter of Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited), has disclosed the sale of 3,41,48,000 shares on September 18, 2025. This transaction reduces Jusmiral Holdings' stake in Cohance Lifesciences from 33.08% (12,65,38,578 shares) to 24.15% (9,23,90,578 shares). The total value of the shares sold is INR 3093,80,88,000.

The proceeds from this sale are primarily intended for the part payment of borrowings under a Notes Purchase Agreement, details of which were previously disclosed on May 9, 2025. This move aligns with earlier disclosures made under Regulations 31(1) and 31(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The disclosure was made in accordance with Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, and was submitted to both the BSE Limited and the National Stock Exchange of India Limited. The transaction was executed on the National Stock Exchange of India Limited through the open market.